Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 15, 2025
Energy-resolved neutron imaging and diffraction including grain orientation mapping using event camera technologyTsviki Y Hirsh, Andrew F T Leong, Adrian S Losko, et al.
Journal of Applied Crystallography|August 7, 2024
Demonstration of neutron time-of-flight diffraction with an event-mode imaging detectorTim T Jäger, Adrian S Losko, Alexander Wolfertz, et al.
Scientific Reports|December 16, 2024
Energy-resolved fast-neutron radiography using an event-mode neutron imaging detectorAlexander Wolfertz, Adrian Losko, Alexander M Long, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal AntibodiesJeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
The Journal of Biological Chemistry|December 7, 2007
c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutationsSteven F Bellon, Paula Kaplan-Lefko, Yajing Yang, et al.
Cancer Cell|July 22, 2014
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activityJonathan D Graves, Jennifer J Kordich, Tzu-Hsuan Huang, et al.
Journal of Medicinal Chemistry|October 28, 2009
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interactionJohn G Allen, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Pageof 4